Press Releases

Month Year

Month Year

Jan 26, 2004

Insmed Obtains Patent Rights for Extreme Insulin Resistance From Fujisawa

Read more
Dec 15, 2003

Insmed Receives FDA Orphan Drug Designation For rhIGF-I/rhIGFBP-3, SomatoKine, for Extreme Insulin Resistance

Read more
Dec 3, 2003

Insmed Presents Positive Data on Anti-Cancer Drug Candidate to San Antonio Breast Cancer Symposium

Read more
Dec 2, 2003

rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes

rhIGF-I/rhIGFBP-3, SomatoKine, Found to Delay the Onset of Type I Diabetes

Read more
Nov 17, 2003

Insmed Presents Positive Data on Anti-Cancer Drug Candidate to AACR-NCI-EORTC

Read more
Nov 5, 2003

Insmed to Present Cancer Data to CaP Cure, the Prostate Cancer Foundation

Read more
Nov 5, 2003

Insmed Incorporated Reports Financial Results for Third Quarter 2003 and Nine-Months Ended September 30, 2003

Read more
Oct 28, 2003

Insmed Incorporated to Webcast Third Quarter Earnings Conference Call; Wednesday, November 5, at 11:00 a.m. ET - 10:00 a.m. CT

Read more
Oct 16, 2003

Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live

Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live

Read more
Sep 23, 2003

Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer

Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation